QCM
TNGX icon

Quantinno Capital Management’s Tango Therapeutics TNGX Stock Holding History

Quantinno Capital Management’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.15M Buy
68,770
+50,326
+273% +$1.24M ﹤0.01% 1914
2026
Q1 		$386K Sell
18,444
-3,895
-17% -$54.2K ﹤0.01% 2887
2025
Q4 		$198K Buy
22,339
+10,064
+82% +$86.7K ﹤0.01% 3053
2025
Q3 		$103K Buy
+12,275
New +$83.1K ﹤0.01% 2877

Other funds holding TNGX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Quantinno Capital Management's TNGX Position: Q2 2026 in Review

Quantinno Capital Management increased its Tango Therapeutics (TNGX) stake by 273% in Q2 2026, buying an estimated $1.24M and bringing the position to 68,770 shares worth $2.15M. The position accounts for ﹤0.01% of the portfolio, ranked #1914.

Quantinno Capital Management first reported a position in TNGX in Q3 2025 and has held it in 4 quarters since. 248 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • Quantinno Capital Management held 68,770 shares of Tango Therapeutics worth $2.15M as of Q2 2026.
  • Quantinno Capital Management bought 50,326 Tango Therapeutics shares in Q2 2026, an estimated $1.24M.
  • Tango Therapeutics made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #1914 holding.
  • Quantinno Capital Management first reported a position in Tango Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • 248 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.